Mostrando 4 resultados de: 4
Filtros aplicados
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(3)
Medicina forense; incidencia de enfermedades(1)
Medicina y salud(1)
Problemas sociales y servicios a grupos(1)
Origen
scopus(4)
CIMAvax-EGF: Toward long-term survival of advanced NSCLC
ReviewAbstract: Lung cancer remains one of the leading causes of cancer-related deaths. Non–small cell lung cancer (Palabras claves:cancer vaccine, CIMAvax-EGF, Clinical trial, EGF, Epidermal growth factor receptor, immunotherapy, non–small cell lung cancerAutores:Camilo Rodríguez, Carmen Elena Viada, Lage Davila A., Mazorra Z., Neninger Vinageras E., Saavedra Hernández D., Tania CrombetFuentes:scopusCOVID-19 and Cancer in Cuba
ArticleAbstract: The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer anPalabras claves:Cáncer, COVID 19, Cuba, infection, Lethality, Mortality , SARS-COV-2Autores:Abreu-Ruíz G., Bermejo-Bencomo W., Lage Davila A., Rubio M.C., Sánchez L., Tania CrombetFuentes:scopusDifferential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer
ArticleAbstract: Background: Progress in immunotherapy has revolutionized the treatment landscape for advanced lung cPalabras claves:immunotherapy, long-term survival, non–small cell lung cancer, survival mixture modelsAutores:Alfonso S., Carmen Elena Viada, Lage Davila A., Luaces P.L.o., Muchene L., Neninger Vinageras E., Rodríguez P.C., Sánchez L., Shkedy Z., Tania CrombetFuentes:scopusNimotuzumab: beyond the EGFR signaling cascade inhibition
ReviewAbstract: One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It activatesPalabras claves:antibody-dependent cell mediated cytotoxicity (ADCC), eGFR, HLA class I molecules, monoclonal antibodies, Natural killer cells, T cellsAutores:Chao L., Iznaga N., Lavastida A., Mazorra Z., Ramos M., Sanchez B., Tania CrombetFuentes:scopus